/

Empresas

Mi

No verificado

Mirum Pharmaceuticals, Inc. and Incyte

Sobre qué escribimos

BiotecnologíaEventosFarmacéuticaHigiene alimentariaMultimedia

2 Comunicados de prensa

Ver todos los comunicados de prensa

14/06/2026

Multimedia

Mercado laboral

Eventos

Industria

Salud

Higiene alimentaria

Medicina - Varios

Ciencia

Farmacéutica

Biotecnología

Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva

Fuente

Mirum Pharmaceuticals, Inc. and Incyte

Editor

1.00

0

04/06/2026

Multimedia

Mercado laboral

Eventos

Ciencia

Biotecnología

Farmacéutica

Oncología

Salud

Higiene alimentaria

Medicina - Varios

Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accepted for Presentation at ENDO 2026

Fuente

Mirum Pharmaceuticals, Inc. and Incyte

Editor

1.00

0

Seguidores

0

Compatibilidad

0